Standout Papers

Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors 1998 2026 2007 2016 995
  1. Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors (1998)
    Pablo Rubinstein, Carmelita Carrier et al. New England Journal of Medicine

Citation Impact

Citing Papers

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help
2003 StandoutScienceNobel
Species Interactions in a Parasite Community Drive Infection Risk in a Wildlife Population
2010 StandoutScience
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection.
1993
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
2006 Standout
Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection.
1993
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
The Natural History of Community-Acquired Hepatitis C in the United States
1992
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Inflammation and cancer
2002 StandoutNature
Routes of Infection, Viremia, and Liver Disease in Blood Donors Found to Have Hepatitis C Virus Infection
1996
Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study
1995
Evolving epidemiology of hepatitis C virus
2010
The Retrovirus Epidemiology Donor Study (REDS): rationale and methods
1995
Parasite interactions in natural populations: insights from longitudinal data
2008
Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay
1991 StandoutNobel
Homozygous and Heterozygous CCR5-Δ32 Genotypes Are Associated With Resistance to HIV Infection
2001
Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease
2001
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
1996 StandoutNobel
ANTI-HEPATITIS C ANTIBODIES AND NON-A, NON-B POST-TRANSFUSION HEPATITIS IN THE NETHERLANDS
1989 StandoutNobel
Transmission of Hepatitis C Virus by a Cardiac Surgeon
1996
Clinical Outcomes after Transfusion-Associated Hepatitis C
1995
Routes of Transimission of Hepatitis C Virus in an Endemic Rural Area of Japan : Molecular Epidemiologic Study of Hepatitis C Virus Infection
1997
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA
1989 StandoutNobel
Lack of Protective Immunity Against Reinfection with Hepatitis C Virus
1992 Science
Adoptive Immune Transfer of Hepatitis B Virus Specific Immunity From Immunized Living Liver Donors to Liver Recipients
2009
Epidemiology of hepatitis C
1997 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Increased detection of hepatitis C virus (HCV)‐infected blood donors by a multiple‐antigen HCV enzyme immunoassay
1992
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Transplanted Human Cord Blood Cells Give Rise to Hepatocytes in Engrafted Mice
2003
Expression and detection of anti-HBs antibodies after hepatitis B virus infection or vaccination in the context of protective immunity
2019
Impact of HIV Type 1 Subtype Variation on Viral RNA Quantitation
1999
Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.
1996 StandoutNobel
Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia
2001
HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN
1989 StandoutNobel
Diagnostic tests for hepatitis C
1997
Hepatitis C Virus RNA Polymerase and NS5A Complex with a SNARE-like Protein
1999
Hepatitis C Virus: Epidemiology, Transmission and Prevention
1998
Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis
1989 StandoutNobel
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
1997 StandoutNature
THE EPIDEMIOLOGY OF ACUTE AND CHRONIC HEPATITIS C
1997
A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan
1989 StandoutNobel
A prospective study of hepatitis C virus infection among renal transplant recipients
1993
Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
1995 StandoutNobel
Virus-induced autoantibody response to a transgenic viral antigen
1990 StandoutNatureNobel
A pattern of 5‐1‐1 and c100‐3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donors
1993
Response to HBV vaccination in patients with severe liver disease
1992
Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
1992
Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen.
1991
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
Reduced Cell Surface Expression of CCR5 in CCR5Δ32 Heterozygotes Is Mediated by Gene Dosage, Rather Than by Receptor Sequestration
2002 StandoutNobel
Towards improvements in molecular tools for diagnosis and management of HIV infections
1999 StandoutNobel
Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma
1990 StandoutNobel
The Risk of Transfusion-Transmitted Viral Infections
1996 Standout
Transmission of hepatitis C in an isolated area in Japan: Community-acquired infection
1994
Hepatitis B virus structure and biology
1989
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Decay characteristics of HIV-1-infected compartments during combination therapy
1997 StandoutNature
HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.
1995 StandoutNobel
Impaired response to hepatitis B vaccine in HIV infected children
1992
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Randomized controlled trial of Hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses
2006
Hepatitis C antibody and chronic liver disease in haemophilia
1990 StandoutNobel
Antibodies to the Core Protein of Lymphadenopathy-Associated Virus (LAV) in Patients with AIDS
1984 StandoutScienceNobel
Hepatitis B virus large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus
1986
The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay.
1995 StandoutNobel
Increased Macrophage Infection upon Subcutaneous Inoculation of Rhesus Macaques with Simian Immunodeficiency Virus-Loaded Dendritic Cells or T Cells but Not with Cell-Free Virus
2002 StandoutNobel
An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis
1989 StandoutScienceNobel
Correction of factor IX deficiency in mice by embryonic stem cells differentiated in vitro
2005 StandoutNobel
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Hepatitis B vaccination for patients with chronic renal failure
2004
The Prevention of Hepatitis B with Vaccine
1982
Structure, sequence and expression of the hepatitis delta (δ) viral genome
1986 StandoutNatureNobel
Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant.
1995 StandoutNobel
Efficient Initiation of HCV RNA Replication in Cell Culture
2000 StandoutScienceNobel
The hepatitis B virus
1985 Nature
Resistance to Replication of Human Immunodeficiency Virus Challenge in SCID-Hu Mice Engrafted with Peripheral Blood Mononuclear Cells of Nonprogressors Is Mediated by CD8+T Cells and Associated with a Proliferative Response to p24 Antigen
2000
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
1996 StandoutNobel
Hepatitis C Virus in the Hemodialysis Setting: A Review with Recommendations for Control
1994
Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation
2002
THE EPIDEMIOLOGY OF VIRAL HEPATITIS IN THE UNITED STATES
1994
Cellular cofactors affecting hepatitis C virus infection and replication
2007 StandoutNobel
T- and B-cell recognition of hepatitis B viral antigens
1988
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors
2000
Prevalence of Hepatitis C Virus Infection in Hemodialysis Patients: A Longitudinal Study Comparing the Results of RNA and Antibody Assays
1993
Antibody response to core, envelope and nonstructural hepatitis C virus antigens: Comparison of immunocompetent and immunosuppressed patients
1993 StandoutNobel
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia
1997 StandoutScience
Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis.
1990 StandoutNobel
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
1997 StandoutScience
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
1998 StandoutScience
Microbial Translocation Across the GI Tract
2012
T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections
1994
Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons
2008
Early events in hepatitis C virus infection of chimpanzees.
1990 StandoutNobel
Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication
2004 StandoutNobel
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
1989 StandoutScienceNobel

Works of Patricia E. Taylor being referenced

Epidemiology of Human Immunodeficiency Virus Type 1 Infection among Homosexual Men Participating in Hepatitis B Vaccine Trials in Amsterdam, New York City, and San Francisco, 1978–1990
1993
Effect of Duration of Hepatitis B Virus Infection on the Association Between Human Immunodeficiency Virus Type–1 and Hepatitis B Viral Replication
1992
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
1998 Standout
Hepatitis B Vaccine in Medical Staff of Hemodialysis Units
1982
Hepatitis B virus contains pre-S gene-encoded domains
1985 Nature
Hepatitis C Virus Infection in Post-Transfusion Hepatitis
1991
Hepatitis B Vaccine in Patients Receiving Hemodialysis
1984
Non-responders to hepatitis B vaccination: a review.
2003
The immune response of healthy adults to a reduced dose of hepatitis B vaccine
1981
Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons
1996
Prospects for Control of Hepatitis B Virus Infection: Implications of Childhood Vaccination and Long-term Protection
1992
Rankless by CCL
2026